Immunological alterations in adult obsessive-compulsive disorder

Biological Psychiatry

Volumn 46, Issue 6, 1999, Pages 810-814

  Marazziti, Donatella ^a   Presta, Silvio ^a   Pfanner, Chiara ^a   Gemignani, Alfredo ^a   Rossi, Alessandra ^a   Sbrana, Silverio ^b   Rocchi, Valeria ^b   Ambrogi, Fabio ^b   Cassano, Giovanni B ^a  

^a Dipartimento di Psichiatria Neurobiologia   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

CD4+ lymphocytes; CD4+ CD8+ ratio; CD8+ lymphocytes; Immune system; Obsessive compulsive disorder; Peripheral immunological cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; LYMPHOCYTE COUNT; MALE; OBSESSION; PRIORITY JOURNAL; SUPPRESSOR CELL;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032871035     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00371-0     Document Type: Article

References (50)

1. Allen A.J., Leonard H.L., Swedo S.E. Case study A new infection-triggered autoimmune subtype of pediatric OCD and Tourette's syndrome . J Am Acad Child Adolesc Psychiatry. 34:1995;307-311.
2. Committee on nomenclature & Statistics Diagnostic and Statistical Manual for Mental Disorders . 4th ed. 1994;American Psychiatric Association, Washington DC.
3. Asberg M., Thoren P., Bertilsson L. Clomipramine treatment of obsessive disorder Biochemical and clinical aspects . Psychopharmacol Bull. 18:1981;13-21.
4. Barber Y., Toren P., Achiron A., et al. T cell subsets in obsessive-compulsive disorder. Neuropsychobiology. 34:1996;63-66.
5. Brambilla F., Perna G., Bellodi L., et al. Plasma interleukin 1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorder. Biol Psychiatry. 42:1997;976-981.
6. Bronze M.S., Dale J.B. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol. 151:1993;2820-2828.
7. Brosschot J.J., Benschop R.J., Godaert G.L., et al. Effects of experimental psychological stress on distribution and function of peripheral blood cells. Psychosom Med. 54:1992;394-406.
8. Denckla M.B., Rapoport J.L. Neurological examination. Denckla M.B., Rapoport J.L. Obsessive-Compulsive Disorder in Children and Adolescents. 1989;107-118 American Psychiatric Press, Washington DC.
9. Feldman B.M., Zabriskie J.B., Silverman E.D., Laxer R.M. Diagnostic use of B-cell alloantigen in rheumatic chorea. J Pediatr. 123:1993;84-86.
10. Fineberg N. Refining treatment approaches in obsessive-compulsive disorder. J Clin Psychopharmacol. 11:(suppl 5):1996;13-22.
11. Gibofsky A., Khanna A., Suh E., Zabriskie J.B. The genetics of rheumatic fever relationship to streptococcal infection and autoimmune disease . J Rheumatol. 18:(suppl 30):1991;1-5.
12. Goodman W.K., Price L.H., Rasmussen S.A. The Yale Brown Obsessive-Compulsive Scale I Development, use and reliability . Arch Gen Psychiatry. 46:1986;1006-1011.
13. Greist J.H., Jefferson J.W., Kobak K.H., Katzelnick D.J., Serlin R.C. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. Arch Gen Psychiatry. 52:1995;53-60.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;189-192.
15. Hoffman-Goetz L., Pedersen B.K. Exercise and the immune system A model of the stress response . Immunol Today. 15:1994;382-387.
16. Hollander E., Cartwright C., Wong C.M., et al. A dimensional approach to autism spectrum. CNS Spectrums. 3:1998;22-39.
17. Hollander E., Fay M., Cohen B., Campeas R., Gorman J.M., Liebowitz M.R. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder Behavioral findings . Arch Gen Psychiatry. 145:1988;1015-1023.
18. Husby G., van den Rijn I., Zabriskie J.B., Abdin Z.H., Williams R.C. Jr. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 144:1976;1094-1110.
19. Insel T.R., Mueller E.A., Alterman I., Linnoila M., Murphy D.L. Obsessive-compulsive disorder and serotonin Is there a connection? Biol Psychiatry. 20:1985;1174-1188.
20. Irwin M., Patterson T., Smith T.L., et al. Reduction of immune function in life stress and depression. Biol Psychiatry. 27:1990;22-30.
21. Khanna S., Ravi V., Shenoy P.K., Chandramuki A., Channabasavanna S.M. Cerebrospinal fluid viral antibodies in obsessive-compulsive disorder in an Indian population. Biol Psychiatry. 41:1997;883-890.
22. Kiessling L.S., Marcotte A.C., Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics. 92:1993;39-43.
23. Knapp P.H., Levy E.M., Giorgi R.G., Black P.H., Fox B.H., Heeren T.C. Short-term immunological effects of induced emotions. Psychosom Med. 54:1992;133-148.
24. Leonard H.L., Swedo S.E., Rapoport J.L., et al. Treatment of childhood obsessive-compulsive disorder with clomipramine and desmethylimipramine in children and adolescents A double-blind cross-over comparison . Am J Psychiatry. 46:1989;1088-1092.
25. Maes M. Evidence for an immune response in major depression A review and hypothesis . Prog Psychopharmacology. 19:1995;11-38.
26. Maes M., Meltzer H.Y., Bosnan E. Psychoimmune investigation in obsessive-compulsive disorder Assay of plasma transferrin, IL-β and IL-6 receptors, and IL-1β and IL-6 concentrations . Neuropsychobiology. 30:1994;57-60.
27. + or suppressor/cytotoxic antigen concentrations in depression Suppressive effects of glucocorticoids . Biol Psychiatry. 40:1996;1273-1281.
28. Marazziti D., Ambrogi A., Vanacore R., et al. Immune cell imbalance in major depressive and panic disorders. Neuropsychobiology. 26:1992;23-26.
29. Marazziti D., Hollander E., Lensi P., Ravagli S., Cassano G.B. Peripheral marker of serotonin and dopamine function in obsessive-compulsive disorder. Psychiatry Res. 42:1992;41-51.
30. 3H-paroxetine binding in obsessive-compulsive patients. Neuropsychobiology. 34:1996;184-187.
31. Marazziti D., Zohar J., Cassano G.B. Biological dissection of obsessive-compulsive disorder. Hollander E., Zohar J., Marazziti D., Olivier B. Current Insights in Obsessive-Compulsive Disorder. 1994;149-166 Wiley, Chichester.
32. Martini E., D'Hautcourt J.L., Lawry J., O'Connor J.E., Sansonetty F. First European Quality Control of Cellular Phenotyping by Flow Cytometry. 1990;Frison-Roche, Paris.
33. Mittleman B.B., Castellanos F.X., Jacobsen L.K., et al. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol. 159:1997;2994-2999.
34. Montgomery S.A. Pharmacological treatment of obsessive-compulsive disorder. Hollander E., Zohar J., Marazziti D., Olivier B. Current Insights in Obsessive-Compulsive Disorder. 1994;215-226 Wiley, Chichester.
35. Montgomery S.A. Long-term management of obsessive-compulsive disorder. J Clin Psychopharmacology. 11:(suppl. 5):1996;23-29.
36. Muller N., Hofschuster E., Ackenheil M., Mempel W., Eckstein R. Investigation of the cellular immunity during depression and free interval Evidence for an immune activation in affective psychosis . Prog Neuropsychopharmacol Biol Psychiatry. 48:1993;201-217.
37. Murphy T.K., Goodman W.K., Fudge M.W., et al. B Lymphocyte antigen D8/17 A peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry. 154:1997;402-407.
38. Nie N.H., Hull C.H., Steinbrenner K., Bent D.H. Statistical Package for the Social Sciences (SPSS). 2nd ed. 1975;McGraw-Hill, New York.
39. Piccinelli M., Pini S., Bellantuono C., Wilkinson C. Efficacy of drug treatment in obsessive-compulsive disorder. Br J Psychiatry. 166:1995;424-443.
40. 3H-imipramine binding in obsessive-compulsive disorder. Biol Psychiatry. 29:(suppl 11):1992;440-441.
41. Sasson Y., Zohar Y. New developments in obsessive-compulsive disorder research Implications for clinical management . J Clin Psychopharmacology. 11:(suppl 5):1996;3-12.
42. Swedo S.E. Sydenham's chorea A model for autoimmune neuropsychiatric disorders . JAMA. 272:1994;1788-1791.
43. Swedo S.E., Leonard H.L., Garvey M., et al. Pediatric Autoimmune Neuropsychiatric Disorders associated with Streptococcal Infections (PANDAS) A clinical description of the first fifty cases . Am J Psychiatry. 55:1998;264-271.
44. Swedo S.E., Leonard H.L., Kiessling L.S. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics. 93:1994;323-326.
45. Swedo S.E., Leonard H.L., Mittleman B., et al. Identification of children with paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 154:1997;110-112.
46. Warren R.P., Margaretten N.C., Pace N.C., Foster A. Immune abnormalities in patients with autism. J Autism Dev Disord. 16:1986;189-197.
47. Weizman R., Laor N., Barber Y., et al. Cytokine production in obsessive-compulsive disorder. Biol Psychiatry. 40:1996;908-912.
48. Zabriskie J.B. Rheumatic fever A model for the pathological consequences of microbial-host mimicry . J Clin Exp Rheumatol. 4:1986;65-73.
49. Zohar J., Insel T.R. Obsessive-compulsive disorder Psychobiological approaches to diagnosis, treatment, and pathophysiology . Biol Psychiatry. 22:1987;667-687.
50. Zohar J., Insel T.R., Zohar-Kadouch R.C., Hill J., Murphy D.L. Serotonergic responsivity in obsessive-compulsive disorder. Effect of chronic clomipramine treatment. Arch Gen Psychiatry. 45:1988;167-172.